Literature DB >> 26350270

MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients.

J F Mendoza Rincón1, A K Rodríguez Elias2,3, J M Fragoso4, G Vargas Alarcón4, K Maldonado Murillo5, M L Rivas Jiménez6, R E Barbosa Cobos7, S Jimenez Morales8, G Lugo Zamudio9, C Tovilla Zárate10, J Ramírez Bello11.   

Abstract

Rheumatoid arthritis (RA) is a multifactorial disease. A combination of genetic and environmental risk factors contributes to its etiology. Several genes have been reported to be associated with susceptibility to the development of RA. The MHC2TA and FCRL3 genes have been associated previously with RA in Swedish and Japanese populations, respectively. In two recent reports, we show an association between FCRL3 and juvenile rheumatoid arthritis (JRA), and MHC2TA and acute coronary syndrome (ACS) in Mexican population. We assessed the association between three single nucleotide polymorphisms (SNPs) of the MHC2TA (-168G/A; rs3087456, and +16G/C; rs4774) and FCRL3 (-169T/C; rs7528684) genes and rheumatoid arthritis in Mexican population through a genotyping method using allelic discrimination assays with TaqMan probes. Our case-control study included 249 patients with RA and 314 controls. We found no evidence of an association between the MHC2TA -168G/A and +1614G/C or FCRL3 -169T/C polymorphisms and RA in this Mexican population. In this cohort of Mexican patients with RA, we observed no association between the MHC2TA or FCRL3 genes and this autoimmune disease.

Entities:  

Keywords:  FCRL3; MHC2TA; Polymorphism; Rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26350270     DOI: 10.1007/s00296-015-3358-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  51 in total

1.  Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations.

Authors:  G Orozco; G Robledo; M V P Linga Reddy; A García; D Pascual-Salcedo; A Balsa; M A González-Gay; A Eimon; S Paira; H R Scherbarth; B A Pons-Estel; I F Petersson; M Alarcón-Riquelme; J Martín
Journal:  Rheumatology (Oxford)       Date:  2006-08-25       Impact factor: 7.580

2.  MHC2TA is associated with rheumatoid arthritis in Japanese patients.

Authors:  Noriko Iikuni; Katsunori Ikari; Shigeki Momohara; Taisuke Tomatsu; Masako Hara; Hisashi Yamanaka; Hiroshi Okamoto; Naoyuki Kamatani
Journal:  Ann Rheum Dis       Date:  2006-11-07       Impact factor: 19.103

3.  FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression.

Authors:  Marthe T Maehlen; Gry B Nordang; Silje W Syversen; Désirée M van der Heijde; Tore K Kvien; Till Uhlig; Benedicte A Lie
Journal:  J Rheumatol       Date:  2011-09-01       Impact factor: 4.666

4.  Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA.

Authors:  Rebeca Dieguez-Gonzalez; Servet Akar; Manuel Calaza; Isidoro Gonzalez-Alvaro; Benjamin Fernandez-Gutierrez; Jose Ramon Lamas; Arturo R de la Serna; Rafael Caliz; Francisco J Blanco; Dora Pascual-Salcedo; Maria Luisa Velloso; Eva Perez-Pampin; Jose Luis Pablos; Federico Navarro; Javier Narvaez; Francisco Javier Lopez-Longo; Gabriel Herrero-Beaumont; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  J Rheumatol       Date:  2009-06-30       Impact factor: 4.666

5.  Role of the MHC2TA gene in autoimmune diseases.

Authors:  Alfonso Martínez; Marta Sánchez-Lopez; Jezabel Varadé; Ana Mas; M Carmen Martín; Virginia de Las Heras; Rafael Arroyo; Juan Luis Mendoza; Manuel Díaz-Rubio; Benjamín Fernández-Gutiérrez; Emilio G de la Concha; Elena Urcelay
Journal:  Ann Rheum Dis       Date:  2006-09-29       Impact factor: 19.103

6.  Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis.

Authors:  K Ikari; S Momohara; T Nakamura; M Hara; H Yamanaka; T Tomatsu; N Kamatani
Journal:  Ann Rheum Dis       Date:  2005-09-21       Impact factor: 19.103

7.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

Review 8.  Cardiovascular disease and rheumatoid arthritis: an update.

Authors:  Christina Charles-Schoeman
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

9.  High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Authors:  Steve Eyre; John Bowes; Dorothée Diogo; Annette Lee; Anne Barton; Paul Martin; Alexandra Zhernakova; Eli Stahl; Sebastien Viatte; Kate McAllister; Christopher I Amos; Leonid Padyukov; Rene E M Toes; Tom W J Huizinga; Cisca Wijmenga; Gosia Trynka; Lude Franke; Harm-Jan Westra; Lars Alfredsson; Xinli Hu; Cynthia Sandor; Paul I W de Bakker; Sonia Davila; Chiea Chuen Khor; Khai Koon Heng; Robert Andrews; Sarah Edkins; Sarah E Hunt; Cordelia Langford; Deborah Symmons; Pat Concannon; Suna Onengut-Gumuscu; Stephen S Rich; Panos Deloukas; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Lisbeth Ärlsetig; Javier Martin; Solbritt Rantapää-Dahlqvist; Robert M Plenge; Soumya Raychaudhuri; Lars Klareskog; Peter K Gregersen; Jane Worthington
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

10.  Sex differences in rheumatoid arthritis: more than meets the eye...

Authors:  Ronald F van Vollenhoven
Journal:  BMC Med       Date:  2009-03-30       Impact factor: 8.775

View more
  5 in total

1.  Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.

Authors:  Daniel Cadena-Sandoval; Isidro Alemán-Ávila; Rosa Elda Barbosa-Cobos; Lizbeth Teresa Becerril-Mendoza; José Manuel Fragoso; Julián Ramírez-Bello
Journal:  Mol Biol Rep       Date:  2018-02-05       Impact factor: 2.316

2.  The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.

Authors:  Daniela Josabeth López-Cano; Daniel Cadena-Sandoval; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Fausto Sánchez-Muñoz; Luis Manuel Amezcua-Guerra; Yaneli Juárez-Vicuña; María Concepción Aguilera-Cartas; José Moreno; Jesús Bautista-Olvera; Guillermo Valencia-Pacheco; Ricardo F López-Villanueva; Julian Ramírez-Bello
Journal:  Inflamm Res       Date:  2017-05-12       Impact factor: 4.575

3.  Tumor necrosis factor gene polymorphisms are associated with systemic lupus erythematosus susceptibility or lupus nephritis in Mexican patients.

Authors:  Julian Ramírez-Bello; Daniel Cadena-Sandoval; Jorge Flavio Mendoza-Rincón; Rosa Elda Barbosa-Cobos; Fausto Sánchez-Muñoz; Luis M Amezcua-Guerra; Mónica Sierra-Martínez; Silvia Jiménez-Morales
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

4.  Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production.

Authors:  Julio E Castañeda-Delgado; Yadira Bastián-Hernandez; Noe Macias-Segura; David Santiago-Algarra; Jose D Castillo-Ortiz; Ana L Alemán-Navarro; Pedro Martínez-Tejada; Leonor Enciso-Moreno; Yolanda Garcia-De Lira; Diana Olguín-Calderón; Leendert A Trouw; Cesar Ramos-Remus; Jose A Enciso-Moreno
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

5.  Functional polymorphisms in pre-miR146a and pre-miR499 are associated with systemic lupus erythematosus but not with rheumatoid arthritis or Graves' disease in Mexican patients.

Authors:  Isidro Alemán-Ávila; Mayra Jiménez-Morales; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Silvia Jiménez-Morales; Fausto Sánchez-Muñoz; Guillermo Valencia-Pacheco; Luis M Amezcua-Guerra; Yaneli Juárez-Vicuña; Dulce Milagro Razo-Blanco Hernández; María Concepción Aguilera-Cartas; Ricardo F López-Villanueva; Oscar Peralta-Zaragoza; Carlos Tovilla-Zárate; Julian Ramírez-Bello
Journal:  Oncotarget       Date:  2017-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.